Global biotechnology leader CSL and sa-mRNA pioneer Arcturus Therapeutics today announced that the European Commission has granted marketing authorization for KOSTAIVE® (ARCT-154), a self-amplifying ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Arcturus' diverse pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19 ... Hepatitis B Virus, and non-alcoholic steatohepatitis (NASH).

You’ve certainly heard about antibodies, peptides, and even DNA as therapeutics ... respectively – use mRNA technology to encode the spike protein of the SARS-CoV-2 virus. Once injected into the body, ...

In addition to SARS-CoV-2, the virus that causes COVID-19, sarbecoviruses — a subgenus of coronaviruses — include the virus that led to the outbreak of the original SARS in the early 2000s.

Covid-19, caused by the SARS-CoV-2 virus, was a new and highly contagious virus that primarily affects the respiratory system. While symptoms of Covid-19 often overlap with hMPV—such as fever, cough, ...

The Trump administration is preparing an executive order that would halt federal funding, at least temporarily, for a risky and controversial kind of research into viruses that makes the pathogens ...